The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma
1997

Gorlin Syndrome and Medulloblastoma

Sample size: 173 publication Evidence: high

Author Information

Author(s): R Cowan, P Hoban, A Kelsey, JM Birch, R Gattamaneni, DGR Evans

Primary Institution: CRC Department of Cancer Genetics, Christie Hospital

Hypothesis

Does the Gorlin syndrome gene act as a tumor-suppressor gene in childhood medulloblastoma?

Conclusion

The Gorlin syndrome gene acts as a tumor-suppressor gene in childhood medulloblastoma, with about 5% of cases linked to this syndrome.

Supporting Evidence

  • Approximately 5% of patients with Gorlin syndrome will develop medulloblastoma in early childhood.
  • 10% of medulloblastomas diagnosed in children under 2 years are associated with Gorlin syndrome.
  • Loss of the wild-type allele on chromosome 9q was observed in medulloblastomas from Gorlin syndrome patients.

Takeaway

Kids with Gorlin syndrome can get a type of brain cancer called medulloblastoma, and it's important to check for this syndrome in young patients with the cancer.

Methodology

The study involved analyzing cases of medulloblastoma and identifying patients with Gorlin syndrome through clinical and radiographic criteria.

Potential Biases

There may be underascertainment of Gorlin syndrome patients in childhood medulloblastoma.

Limitations

The study may not capture all cases of Gorlin syndrome due to the age-dependent nature of its features.

Participant Demographics

Patients included children diagnosed with medulloblastoma, some of whom were identified as having Gorlin syndrome.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication